ABSTRACT
INTRODUCTION H
UMAN EMBRYONIC STEM CELL (hESC) lines were first derived from the inner cell mass of preimplantation embryos (Reubinoff et al., 2000; Thomson et al., 1998) . They can be maintained in vitro for extended periods without losing their self-renewal or developmental potential to give rise to cell types representing endoderm, mesoderm, and ectoderm germ layers as assessed in vitro through embryoid body (EB) formation or in vivo by teratoma formation (Chadwick et al., 2003; Itskovitz-Eldor et al., 2000; Kehat et al., 2001; Levenberg et al., 2002; Lumensky et al., 2001; Nistor et al., 2004; Xu et al., 2002) . Based on these biological characteristics, hESCs are expected to open up new avenues in regenerative medicine by allowing the generation of transplantable cells to be used in future cell replacement therapies (Lebkowski et al., 2001; Menendez et al., 2006) .
Several fundamental questions regarding optimization of in vitro culture conditions for proper maintenance, differentiation, and genetic manipulation of hESCs and their derivatives are major challenges that need to be overcome before any potential cell replacement therapy can even be considered. Maintenance of hESCs in the presence of xenogenic compounds is likely to prevent their use in future therapeutic applications in humans. Thus, alternative culture systems that do not depend on animal-derived extracts have also been investigated. Recent reports aimed to develop xeno-free culture systems have documented the successful long-term maintenance of hESCs on feeder layers derived from human foreskin (Amit et al., 2004; Hovatta et al., 2003) or human adult bone marrow (BM) stromal cells (Cheng et al., 2003; Menendez et al., 2005) , although in both cases the hESC culture medium still needs to be supplemented with basic fibrobast growth factor (bFGF).
The use of "feeder" cells of murine (MEFs) or human origin to maintain the undifferentiated growth of hESC cultures provides intimate contact between hESCs and the feeders. In addition, all these feeders are derived from mice or human donors, and these should be screened for some micro-organisms (mainly viruses), to avoid the transmission of pathogens.
We propose that stem cell banks and other research centres working with hESC lines should implement adequate microbiological quality assurance programs. Stem cell banks should provide researchers with procedures and protocols for viral testing to assure the quality and safety of the stem cell lines. Detection of viruses in the cells may be assayed by molecular methods and by in vivo and in vitro assays for virus detection. However, the accurate diagnosis of this viral contamination is very demanding because the nature of viral particles capable of infecting the cell cultures is very wide. To date, several viral screening approaches in human (Minor, 1994 (Minor, , 2004 and murine cell cultures (Kraft and Meyer, 1990 ) have been described. However, it becomes crucial to study and characterize in depth the possible presence of viruses and other contaminants in stem cell cultures for human transplantation purposes, indicating the need of additional studies. Moreover, some of the diagnostic methods are longstanding techniques that require the need for specialized facilities and expertise to be capable of detecting the viral particles and assessing the viral load in any given cell (Cobo et al., 2005 . In contrast, transmission electron microscopy has some advantages, and could be a complementary, fast, and easy-to-perform method to be implemented in stem cell banks to carry out a proper and reliable diagnosis of viral contaminants by means of direct visualization of viral particles in the cell cultures. In the present preliminary study, we have implemented this electron microscopybased microbiological diagnostic strategy in our Spanish stem cell bank and found that three out of nine (33%) of MEF samples used for hESC maintenance contain the presence of viral particles while none of the HEF samples and human BM-derived mesenchymal cells used as feeders contained such contaminants, supporting previously reported hESC maintenance methods (Cheng et al., 2003) using human cells as feeders.
MATERIALS AND METHODS

Human ESC maintenance
Undifferentiated hESC lines HS181 and HS293 (Hovatta, et al., 2003) were kindly provided by Prof. Outi Hovatta (Karolinska Institute, Stockholm) and maintained in tissue cultured T25 flasks (BD Biosciences, Bedford, MA) over a confluent layer of either inactivated murine or human feeders in hESC media consisting of 80% Knockout-DMEM supplemented with 20% Knockout Serum replacement (SR), 1% nonessential amino acids, 1 mM L-Glutamine (all from Invitrogen, Carlsbad, CA), 0.1 mM ␤-mercaptoethanol (Sigma-Aldrich, Oakville, ON, Canada), and 8 ng/mL of bFGF. To maintain undifferentiated growth, the hESC media was changed daily and hESCs were passaged (1:2 or 1:3) weekly by dissociation with 200 U/mL of Collagenase IV (Invitrogen) (Stewart et al., 2006; .
MEFs, HEFs, and human BM-derived mesenchymal cells harvesting and maintanance
The presence or absence of either murine or human viruses was assessed in MEFs, HEFs, and human BM-derived mesenchymal cells.
MEFs from CF-1 mouse strain (n ϭ 9) were harvested as follows. At 13.5-day of pregnancy, embryos were removed from the embryonic sac and then dissected out and the placenta and membranes discarded. Embryos were then decapitated and eviscerated. After several washes in PBS, the carcasses were placed in a Petri dish and minced with a scalpel blade for a while. The tissue was then treated with trypsin:EDTA at 37°C for 10-20 min to disaggregate the cell clumps and washed several times with DMEM ϩ FCS. Large cell aggregates were allowed to settle down by gravity and the supernatant containing single cells was plated into a T75 flask in DMEM ϩ FCS. The following day, the medium was replaced by fresh media to remove floating cellular debris and the MEFs allowed to grow until they reached 90% confluence ( Fig. 1A and B) . When ready to be used as feeders for hESCs, MEFs were seeded onto culture flaks at 1 ϫ 10 5 cells/cm 2 and inactivated using Mitomycin at 10 g/mL for 2 h. Different batches of foreskin-derived HEFs were maintained in our Stem Cell Bank for over 15 months. For hESC maintenance, foreskin-derived HEFs were seeded onto culture flaks at 1 ϫ 10 5 cells/cm 2 and inactivated using Mitomycin at 10 g/mL for 2 h.
Mesenchymal cells were obtained from the BM aspirates of human healthy donors (n ϭ 9) as previously described (Friedenstein et al., 1970; Lazarus et al., 1995; Quarto et al., 2001 ). All human donors have given their informed consent. Briefly, BM aspirates were obtained in heparinized tubes. Mononuclear cells were isolated by Ficoll density centrifugation (400 ϫ g, 25 mins, 20°C) and washed with PBS by sedimentation (600 ϫ g, 5 min, RT). The cells were resuspended in MSCBM basal medium (SingleQuot ® Kit (PT-4105); purchased from Cambrex, Rocklan, ME) plus MSCGM (BulletKit ® (PT-3001); purchased from Cambrex) and seeded onto culture flaks at 3 ϫ 10 4 cells/cm 2 . The MSCGM contains a minimum essential medium, albumin, an iron source, insulin, glutamine, and a mitogen. After 24 h, nonadherent cells were removed by washing with PBS. Attached cells were cultured in MSC medium at 37°C and 5% CO 2 . After the four passages, we obtained a homogenous population of MSC that were characterized by flow cytometry ( Fig. 1C and D) .
Immunophenotypic characterization of human BM-derived mesenchymal cells
To characterize the mesenchymal cells we use the following antibodies: CD44, CD45, CD34, CD90, CD105, and HLA-DR. Monoclonal antibodies were conjugated to fluorescein isothiocyanate or phycoerythin (BD Biosciences/ Pharmingen, San Jose, CA). Each fluorescence analysis included a negative isotype control immunoglobulin. Cells were analyzed in an EPICS XL-MCL cytometer (Coulter Electronics, Hialeah, FL) (Fig. 1E) .
Sample processing for electron microscopy
The cell monolayers were stained by means of an inclusion and ultramicrotomy technique (Biel and Gelderblom, 1999) . Briefly, the cells were washed with PBS and were fixed in a buffer with glutaraldehyde (1.5%), formaldehyde (1%), and cacodylate (0.05 M) for 4 h. The inclusion medium was the contrast epoxy resin (EMBED 812, EMS, PE, USA). After this, the specimens were stained in aqueous solution of uranyl acetate. Finally, these specimens were cut in thick sections (500-700 m) with an ultramicrotome (Reichert Ultracut S, Leica, Vienna, Austria). The electron microscope used for the specimen analysis was the Carl Zeiss Oberkochen ® model EM 10°C. The work voltage was 80 KV and the film photograph was Kodak ® Electron microscope film. Three grids (never single) were viewed per sample. Each grid has four sections and we looked at 8-10 cells per section, indicating that 32-40 cells per section and, therefore, about 96-120 total cells were carefully analyzed for each individual sample. Importantly, the sections were done randomly in multiple areas of the cultures and the virological analysis and final report was performed by a specialist virologist.
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RESULTS
Recently, Cheng et al. (2003) reported that human adult BM cells have the ability to support prolonged expansion of hESCs in culture similar to murine feeders. Here, in an attempt to minimize the use of xenogenic components for hESC maintenance and subsequent differentiation, we performed electron microscopy-based microbiological studies to determine the potential presence of viral particles in MEFs compared with foreskin-derived HEFs and human BM-mesenchymal cells. Figure 1A and C shows an established culture of MEFs and BM-derived mesenchymal cells, respectively. Figure 1B and D shows representative pictures of hESCs growing on MEFs and human HEFs or BM-derived mesenchymal feeders, respectively. Human BMderived mesenchymal cells had the previously described mesenchymal immunophenotype: CD44ϩ, CD105ϩ, CD90ϩ, HLAϪDRϪ, CD34Ϫ, and CD45Ϫ.
Using electron microscopy, we have visualized 96-120 cells for each independent sample (n ϭ 9 MEF batches, n ϭ 5 HEF batches, and n ϭ 9 BMderived mesenchymal cells from nine BM samples from healthy donors). The specialized virologist with extensive expertise in transmission electron microscopy observed in three out of nine (33.3%) MEF samples ( Fig. 2A and Table 1 ) viruses belonging to the Retroviridae family (approx. 100 nm diameter). Within the Retroviridae family, these viruses have a C morphology, which indicates that they belong to the subfamily Orthoretroviridae. The transmission electron-microscopy studies allowed us to rule out the presence of Lentivirus and Spumavirus due to their completely different appearance and morphology. In contrast, no viral particles of any type could be observed in human BM-derived mesenchymal cells here analyzed ( Fig. 2B 
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Electron microscopy microphotograph (50,000ϫ high magnification) of a murine feeder cell. In the interstitial space, many typical particles (100 nm) with type C morphology (Orthoretrovirus) can be observed, which seem to correspond to Murine Leukemia Virus (MLV). Black arrow indicates the viral particles. (B) Electron microscopy microphotograph (50,000ϫ high magnification) of a human feeder cell free of viral particles. (C) Electron microscopy microphotograph (50,000ϫ high magnification) of a human foreskin-derived embryonic fibroblast free of viral particles.
DISCUSSION
Owing to their unique biological properties, hESCs are expected to open up new avenues in regenerative medicine by permitting the in vitro generation of transplantable cells to be used in future cell replacement therapies. However, we need to bear in mind that hESC research represents a nascent area of investigation, and therefore, many fundamental questions regarding the nature of hESC cultures and their in vivo behavior still need to be addressed (Menendez et al., , 2006 Stewart et al., 2006) .
The current success in delivering cell populations and demonstrating their functional capacity in vivo is very limited, underlying that for this application to advance to the next step several fundamental issues must be addressed. The first issue relates to the type, number, and maturation stage of the cells that will be transplanted. A second concern relates to the development of teratomas as a result of transplantation of undifferentiated hESCs. Transplantable populations derived from hESCs must be highly purified, and contain only the cells expected to replace the diseased tissue without any contamination by undifferentiated cells that might originate teratomas in the recipient. Another downside associated to hESC-based cell therapies lies with the fact that transplanted cells are of allogeneic origin, and therefore, may be recognized as foreign by the host's immune system, inducing graft rejection and subsequent undesirable consequences. To overcome these hurdles, demanding efforts still need to be undertaken to achieve a near-full understanding of the mechanisms regulating the behavior of these cells.
Another major and short-term drawback in hESC research is the optimization of in vitro culture conditions to maintain the hESC in an undifferentiated state. Current protocols for derivation of ESCs from human embryos are basically adapted from the mouse and require a MEF feeder layer (Evans and Kaufman, 1981; Richards et al., 2002) . Over the past years new reports have suggested that hESCs can be maintained in longterm culture using feeder-free conditions in which hESCs are cultured on Matrigel or laminin in media conditioned by MEFs (Ludwig et al., 2006; Stewart et al., 2006; Thomson et al., 1998; Xu et al., 2002) or on feeders of human origin such as foreskin-derived human COBO ET AL. 6 Abbreviations: MEFs; murine embryonic fibroblasts; HEFs, human skin-derived embryonic fibroblasts; BM, bone marrow. embryonic fibroblast or, more available and amenable, mesenchymal cells from BM (Cheng et al., 2003) . To date, however, the majority of hESC accepted for research by the National Institute of Health have been isolated either using MEFs or using conditioned medium made from these fibroblasts. The requirement for MEFs to maintain undifferentiated growth of hESC cultures is likely to enhance the possibility to transmit infectious pathogens to the hESC and their differentiated derivatives. There is evidence that certain mouse viruses have caused serious infections in laboratory workers (Lloyd and Jones, 1986; Mahy et al., 1991) . Moreover, in the European Medicines Evaluation Agency's guidelines (1997), there is also evidence that other mouse viruses are capable of infecting human or primates (European Medicines Evaluation Agency). For these reasons, while many efforts are in place worldwide to develop a reliable feeder-free hESC culture method, the application of a program of viral screening is necessary in the decision-making process on how and when MEFs may be used in stem cell cultures, not only for potential clinical use but also for basic research.
Very recently, a variety of countries such as the United Kingdom, Sweden, Spain, and the United States have set up stem cell banks not only to make hESC lines available to other scientists but also to speed up hESC research. We consider that a prospectively and accurate microbiological control of the stem cell cultures should be carried out to minimize the presence of any potential contaminants including bacteria, yeast, fungi, prions and viruses (both of human or animal origin), which will be easily and freely transmitted to the recipients of the final mature and functional hESC derivatives. Accordingly, in addition to the current incorporation of this transmission electron microscopy strategy, our Stem Cell Bank has been developing over the last 2 years novel initiatives and technical tools to make the microbiological control in stem cell banks more accurate and exhaustive (Cobo et al., 2005 Cobo and Concha, 2007; Stacey et al., 2006) Viruses are one of the main micro-organisms that can contaminate stem cell cultures and "feeder" cells in stem cell banks and independent research centers. However, the diagnosis of this viral contamination is very demanding because the nature of viral particles capable of infecting the cell cultures is very wide and some of the diagnostic methods are long-standing techniques and require the need for specialized facilities and expertise to be capable of detecting the viral particles. All human cells (e.g., embryos, bone marrow, umbilical cord blood) have the potential to transmit infectious diseases to the recipient. In the past, donors have been screened for some viruses like human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus. This screening should be carried out using currently available protocols like those based on the detection of donor antibody response to viral infection and, in certain cases, by means of the addition of nucleic acid test (NAT) methods. Other viruses that could be included in the screening are CMV and, in certain circumstances, HTLV-I/II. Although this list might be expanded even further in light of developing knowledge and technology, it is inevitable that a balance will be drawn between the associated risk of infection and the resources and time required to perform a complete viral screening program. Within this viral screening program, some tests should be necessarily included such as reverse transcriptase detection and molecular techniques (e.g., PCR, RT-PCR). Furthermore, we propose that despite its sensitivity limitations transmission electron microscopy, may facilitate not only the detection of different kinds of viral particles but also the characterization of many unknown viral particles present in cell cultures (Cobo et al., 2005 Stacey et al., 2006) .
In our Spanish stem cell bank, therefore, we have implemented a transmission electron microscopy strategy to screen all the mouse and human feeders being used for hESC coculture. The transmission electron microscopy was first described by Max Knoll and Ernst Ruska (1932) . This method could have a role as a diagnostic tool for the investigation of viruses in stem cell cultures. The lack of requirement for viral viability, the investigation of new infectious agents and the use of this technique as a method to diagnose many different kinds of viral particles, are some of the advantages for using electron microscopy rather than other techniques. Moreover, this method could provide additional information about infectious agents, and in our opinion should become a complementary technique for the viral diagnosis.
In the present preliminary study, we have implemented this diagnostic strategy in our Spanish stem cell bank and found that three out of nine (33%) of MEFs used for hESC maintenance contain plenty of Orthoretroviridae viral particles
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while none of the HEFs and human BM-derived mesenchymal cells here analyzed contained such contaminants. Taken together, we recommend the implementation of transmission electron microscopy as a routine technique to assess the potential presence of viral particles in any feeder cell used in stem cell banks and support, as previously described (Cheng et al., 2003) , the use of cells of human origin (mesenchymal cells or foreskin-derived cells) rather than their murine counterparts as feeders to maintain hESC cultures undifferentiated. However, it must be pointed out that the interpretation of the electron microscopy images should be carried out by highly experienced personnel, because occasionally it is possible to find similar virus-like structures named as "coated pits" with pseudospeckles that correspond to the clathrin cover and can easily be confused with viral particles.
In our opinion, the discovery of the presence of viruses in MEFs but not in human feeders would help to better optimize hESC culture conditions. Furthermore, regarding laboratory workers, special work facilities such as current Good Manufacturing Practice (cGMP) rooms should be in place to diminish the transmission to the technical workers, although it should be pointed out that the first protection for lab workers handling potential viral-infected material must take place at the donor screening level. In conclusion, we report preliminary but very novel microbiological data, which supports the need for feeder-free hESC cultures to avoid the use of MEFs and the possible transmission of murine viruses to hESCs.
